Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyAlison Stopeck, Ada Braun, Allan Lipton et al.|Journal of Clinical Oncology|2010Cited by 1.6k
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trialsAllan Lipton, Susie Jun, Michael Clemens et al.|European Journal of Cancer|2012Cited by 588
Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor ReceptorU. Vanhoefer, José Baselga, Mitra Tewes et al.|Journal of Clinical Oncology|2003Cited by 259
Denosumab for Treatment of Hypercalcemia of MalignancyMimi I. Hu, Rajul K. Jain, Sophie Leboulleux et al.|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 200
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison Stopeck, Ada Braun, Karim Fizazi et al.|Supportive Care in Cancer|2015Cited by 190